SCHEMBL904496

SCHEMBL904496

OCCOc1ccccc1-c1ccccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.53
JAK2 O60674 1/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
IDO1 P14902 1/20 0.53
TP53 P04637 1/20 0.49
MAPK1 P28482 1/20 0.49
RAB9A P51151 1/20 0.49
ALDH1A1 P00352 3/20 0.48
HPGD P15428 1/20 0.48
BCL2L1 Q07817 1/20 0.48
HSD17B10 Q99714 1/20 0.48
HTT P42858 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HTR7 P34969 1/20 0.46
PDE5A O76074 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
RECQL P46063 1/20 0.45
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1938309 0.90 TP53 (0.57) LMNAIDO1TP53MAPK1RAB9A
SCHEMBL27317852 0.88 LMNA (0.57) LMNAJAK2GAAMAPTIDO1
SCHEMBL1030614 0.84 GAA (0.75) LMNAJAK2GAAMAPTIDO1
SCHEMBL6675757 0.83 LMNA (0.52) LMNAJAK2GAAMAPTTP53
SCHEMBL8736657 0.83 LMNA (0.52) LMNAJAK2GAAMAPTIDO1
SCHEMBL29418129 0.82 TP53 (0.69) LMNATP53MAPK1RAB9AALDH1A1
SCHEMBL159005 0.82 TP53 (0.69) LMNATP53MAPK1RAB9AALDH1A1
SCHEMBL27555571 0.81 GAA (0.55) LMNAJAK2GAAMAPTTP53
Di(Hydroxyethyl)Ether SCHEMBL10631967 0.79 ALDH1A1 (0.50) LMNAJAK2GAAMAPTIDO1
SCHEMBL9257284 0.79 LMNA (0.53) LMNAJAK2GAAMAPTPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946367-B2 Polymerizable carbamate and thiocarbamate compounds, polymers derived from them, and compositions thereof ISP INVESTMENTS INC. (US) 2015-02-03 US disclosed
US-20130090443-A1 POLYMERIZABLE CARBAMATE AND THIOCARBAMATE COMPOUNDS, POLYMERS DERIVED FROM THEM, AND COMPOSITIONS THEREOF ISP INVESTMENTS INC. (US) 2013-04-11 US disclosed
WO-2011163317-A2 POLYMERIZABLE CARBAMATE AND THIOCARBAMATE COMPOUNDS, POLYMERS DERIVED FROM THEM, AND COMPOSITIONS THEREOF ISP INVESTMENTS INC. (US) 2011-12-29 WO disclosed
EP-0551867-B1 Laminated transparent plastic material and polymerizable monomer MITSUI CHEMICALS INC (JP) 2000-06-07 EP disclosed
US-5451695-A Acrylic ester monomer with carbamate group, glazing for windows MITSUI TOATSU CHEMICALS, INC. (JP) 1995-09-19 US disclosed
US-5393607-A Glazing materials; hardness, impact strength, scratch resistance MITSUI TOATSU CHEMICLAS, INC. (JP) 1995-02-28 US disclosed
EP-0551867-A1 Laminated transparent plastic material and polymerizable monomer MITSUI TOATSU CHEMICALS, Inc. (JP) 1993-07-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090443-A1 POLYMERIZABLE CARBAMATE AND THIOCARBAMATE COMPOUNDS, POLYMERS DERIVED FROM THEM, AND COMPOSITIONS THEREOF CUTA, CTH, ACOT7 LMNA 4550/4885JAK2 4611/4885GAA 4069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.